Mikael Søndergaard Thomsen
Founder at INITIATOR PHARMA A/S
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Bondo Hansen | M | - |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | 14 years |
| Claus Elsborg Olesen | M | 50 | 8 years | |
| Henrik Kristian Moltke | M | 66 | 8 years | |
| Gunnar Magnus Modee Persson | M | 64 | 8 years | |
| Gunilla Anders Ekström | M | 66 | 2 years | |
| Annette Colin Lövgren | F | 59 | 3 years | |
| Niels Skjærbæk | M | - |
Conrig Pharma ApS
Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | - |
| Peter Holm | M | 50 | 8 years | |
| Ulf Simonsen | M | 61 | 8 years | |
| Torgeir Vaage | M | 60 | 8 years | |
| Allan Wehnert | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dan Peters | M | 63 | - | |
| Joseph deBethizy | M | 74 |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mikael Søndergaard Thomsen
- Personal Network
